​Infec​tious Disease Research


​Project
​Granting Agency
​Principal Investigator
​Duration
​COVID-19 HH Transmission study in Pakistan
​Bill & Melinda Gates Foundation
​Imran Nisar
​25/08/2020 to 31/12/2023
​Covid-19, Burial Site Surveillance to Measure Excess Mortality - Pakistan​​
​UT Southwestern Medical Center​
​Momin Kazi
​01/07/2021 to 31/12/2023
​Randomized Controlled trial to assess the immunogenicity, safety and reactogenicity of full dose versus fractional dose of Pfizer/BioNTech, AstraZeneca, and Sinovac-CoronaVac COVID-19 vaccines given as an additional dose at least 6 months after full vaccination or PCR-Confirmed infection with SARS-Cov-2 in Healthy Adults
​Albert B. Sabin Vaccine Institute, Inc
​Farah Qamar
​01/05/2022 to 31/03/2024
​Supplement for Long Covid/University of Washington Arboviral Research Network
​University of Washington
​Najeeha Talat
​16/09/2022 to 30/04/2024
​Optimizing place of treatment and antibiotic regimens for young infants presenting with signs of possible serious bacterial infection (PSBI)
​World Health Organization
​Fyezah Jehan
​11/03/2020 to 31/12/2023
​Environmental Surveillance in Pakistan
​Bill & Melinda Gates Foundation
​Farah Qamar
​01/11/2020 to 30/06/2024
​University of Washington Arboviral Research Network & Supplementary budget
​University of Washington
​Najeeha Talat
​01/12/2020 to 30/04/2025
​GPS2: Global Pneumococcal Sequence surveillance 2.0
​Wellcome Sanger Institute
​Imran Nisar
​31/08/2022 to 30/11/2023​
​Global Human Papillomavirus burden Study
​International Vaccine Institute
​Fyezah Jehan
​01/04/2023 to 31/12/2026
​Evaluating pneumococcal carriage and changes in serotype distribution after a switch from PCV10 to PCV13 in children in a rural site in Matiari, Pakistan
​Pfizer Inc
​Imran Nisar
​01/06/2023 to 30/06/2025
​Understanding the ecology of ESBL-producing Enterobacteriaceae for the prevention of infection
​Northwestern University/NSF
​Mehreen Arshad
​01/01/2024 to 31/12/2028​
​Predicting ARDS and subtyping Human pediatric Sepsis

​The Children's Hospital Of Philadelphia
​Sidra Ishaque
​01/10/2020 to 30/06/2024
​Using Lactate Testing to Improve maternal sepsis identification : a multi-country test accuracy study and feasibility assessment
​Medical Research Council (UoL)
​Lumaan Sheikh
​01/01/2022 to 30/09/2024
​Genomic of Klebsiella Pneumonia and Neonatal Sepsis in Pakistan
​Bill & Melinda Gates Foundation
​Imran Nisar
​01/07/2022 to 30/06/2024
​SHIPSS

​CHEO RI, KK Women's and Children's Hospital 
​Qalab-e-Abbas
​01/01/2024 to 01/12/2026
​Association between antimicrobial resistance pattern of Salmonella typhi with anti Vi lgG titers following administration of single dmie of typhoid conjugate vaccine (Typebar-TCV) among children aged 6 months to 10 years in Hyderabad, Pakistan
​Albert B. Sabin Vaccine Institute, Inc
​Farah Qamar
​01/01/2019 to 31/12/2023
​Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of un complicated typhoid in South Asia; a randomised controlled trial
​The Chancellor, Masters and Scholars of the University of Oxford
​Farah Qamar
​09/04/2021 to 31/03/2024



​TCV - Modelling Project for Typhoid
​Sabin Vaccine Institute
​Farah Qamar
​01/01/2023 to 30/04/2025
​Perinatal Transmission of MDR Gram-negatives and Infant Health

​NIH
​Fyezah Jehan
​01/07/2024 to 30/06/2029
​Perinatal Transmission of MDR Gram-negatives and Infant Health
​Anne & Robert Lurie Children's Hospital 
​Fyezah Jehan
​01/01/2025 to 31/12/2029
​A Phase II, Randomized, Observer-blinded, Placebo Controlled Trial to Evaluate the Safety and Immunoge​​nicity of Euvichol-S in Healthy Pregnant Women between Gestational Age 14-36 weeks and Non-Pregnant Women of 18-45 years old / Open-label Trial to Evaluate the Safety and Immunogenicity of Euvichol-S in HIV positive and negative participants of 18-45 years old
​International Vaccine Institute
​Imra​​n Nisar
​01/06/2024 to 31/08/2026